What Weild & Co. does

Weild & Co. (legal entity Weild Capital, LLC) is a privately held, FINRA-registered broker-dealer founded in 2012 and headquartered in Boulder, Colorado, with a parent office in New York. The firm operates a decentralized investment banking model in which independent investment bankers and placement agents house their FINRA licenses through Weild & Co. and collaborate remotely via a cloud-based platform to deliver corporate finance and capital raising services. The firm is led by David Weild IV, a former NASDAQ Vice Chairman widely referred to as the 'Father of the JOBS Act,' whose policy work and 1,000+ career public equity offering transactions anchor the firm's regulatory and capital-markets expertise.

The firm generates revenue through transaction fees across six core services: private placements (equity, debt, hybrid, bridge financing), M&A advisory (sell-side and buy-side), public company advisory (IPOs and follow-ons), fund raises, fairness opinions, and SPAC advisory. Service delivery is organized through vertical practices spanning Life Sciences, Financial Services, Technology, Venture Funds, Clean Energy, Digital Assets, Electric Vehicles, Oil & Gas, Real Estate, and Sustainability. The Life Sciences practice is the most developed, with a dedicated team that has executed 130+ M&A deals over the past decade for clients including Dexcom, Gore, GE, IBM, and Medtronic. Senior management is involved in every engagement, and the firm does not work with startups, focusing instead on established issuers with proven leadership.

The go-to-market combines thought leadership (published studies on market structure, congressional testimony, TEDx presentation), earned media (Forbes, Inc., IBD), and a network-driven model in which the platform distributes services through its independent banker base while maintaining direct client relationships on the senior team. The firm holds FINRA and SIPC memberships, files Form CRS under SEC Regulation Best Interest, and maintains an AML/CIP program, providing the regulatory and compliance backbone that allows independent bankers to operate under its broker-dealer umbrella.

Name

Weild & Co.

Legal name

Weild Capital, LLC

Website

https://weildco.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Weild & Co. is a privately held FINRA-registered broker-dealer that operates a cloud-based decentralized investment banking platform, enabling independent bankers to deliver private placements, M&A advisory, IPO advisory, fund raises, fairness opinions, and SPAC advisory to middle-market issuers across multiple verticals.

Ownership category

akta.pro rank

Product category

Investment Banking & Capital Markets Advisory

NAICS

Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Securities and Commodity Contracts Intermediation and Brokerage (5231), Portfolio Management and Investment Advice (52394)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282), Finance Services (6199)

akta.pro primary industry

Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

akta.pro secondary industries

M&A Advisory (Buy-side/Sell-side) (BPAHADAC), Fairness Opinions & Independent Financial Advice (BPAHAOAF), Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ), Treasury, Capital Structure & Liquidity Advisory (BPAHADAM)

Keywords

• Investment banking services
• Capital markets advisory
• Private placements
• Mergers and acquisitions
• IPO advisory

Headquarters

HQ city

Boulder

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Private Placements: Fees from helping companies raise capital for growth, project financing, regulatory approvals across various security structures including equity, debt, hybrid securities, and bridge financing
2. Mergers & Acquisitions Advisory: Advisory fees from M&A transactions, with over a quarter of closed transactions focused on M&A for sell-side and buy-side engagements
3. Public Company Advisory: Advisory services for initial public offerings and follow-on offerings, including security pricing, aftermarket support, and compliance guidance
4. Fund Raises: Advisory services for venture fund managers with positive track records, including financial services, insurance, technology, real estate, energy, and opportunistic funds
5. Fairness Opinions: Fees for financial fairness assessments of proposed transactions including mergers, acquisitions, buybacks, or business purchases
6. SPAC Advisory: Internal advisory branch supporting SPAC-related transactions including preparation and identification of potential SPAC mergers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Weild & Co. is an issuer-focused investment bank and FINRA/SIPC registered broker-dealer that delivers corporate finance and capital raising services — including private placements, M&A advisory, public company advisory (IPOs and follow-on offerings), fund raises, fairness opinions, and SPAC advisory — through a cloud-based decentralized platform that connects independent investment banking professionals. The firm serves middle-market and established companies across sectors such as Life Sciences, Financial Services, Technology, Clean Energy, Digital Assets, and Electric Vehicles, providing transaction advisory, security structuring, regulatory navigation, and distribution support via its banker network.

Product overview

Weild & Co. operates as a decentralized investment bank offering a unified platform with multiple integrated service modules. The core Weild & Co. Platform enables registered financial professionals to deliver corporate finance services including Private Placements, Mergers & Acquisitions Advisory, Public Company Advisory, Fund Raises, Fairness Opinions, and SPAC Advisory. Specialized vertical services like Life Sciences Banking build on this platform foundation, providing sector-specific expertise in medical devices, diagnostics, pharmaceuticals, and biotechnology. The platform also provides shared services including document libraries, structuring and diligence support, and regulatory compliance assistance (FINRA/SEC navigation). The services are designed to work together, with bankers able to leverage internal resources, industry expertise, and distribution networks across the platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Placements Capital-raising services for companies seeking growth financing, project financing, regulatory approvals, and other purposes across multiple security structures including equity, debt, hybrid securities, and bridge financing. Targeted at established private companies needing access to institutional capital.
• Mergers & Acquisitions Advisory M&A advisory services covering both sell-side and buy-side transactions for public companies, private equity firms, and family offices, including target/acquirer identification and transaction structuring. More than a quarter of the firm's closed transactions are M&A engagements.
• Public Company Advisory Advisory services for initial public offerings and follow-on offerings, providing expertise in security pricing, aftermarket support, compliance, and industry trends for public companies and pre-IPO issuers.
• Fund Raises Advisory and support services for seasoned venture fund managers with positive track records, spanning financial services, insurance, technology, real estate, energy, and opportunistic funds.
• Fairness Opinions Financial fairness assessments for proposed transactions including mergers, acquisitions, buybacks, or other business purchases, provided by senior bankers to boards and special committees.
• SPAC Advisory Special Purpose Acquisition Company advisory services to support clients in preparing for and identifying potential SPAC mergers.
• Life Sciences Banking Investment banking services tailored for life sciences organizations including medical devices, diagnostics, pharmaceuticals, biotechnology, and nutraceutical companies, encompassing M&A, corporate finance, strategic advisory, and capital formation. The firm has closed 130+ Life Sciences M&A deals in the last 10 years and serves clients such as Dexcom, Gore, IBM, GE, and Medtronic.
• Weild & Co. Platform A cloud-based decentralized platform enabling independent investment bankers and financial professionals to deliver corporate finance and capital raising services, featuring shared services, regulatory support, document libraries, and distribution capabilities across family office, lending, PE, and VC coverage groups.

Quantifiable outcome

• $3bn+ in closed transactions across the network
• +2 more outcomes

Named customers5 records

Segments15 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Stonybrook CapitalminorStrategic or Co-development PartnerStrategic alliance with Stonybrook Capital, mentioned in press coverage. Stonybrook Capital is a financial services firm with which Weild & Co. formed a strategic alliance for capital formation services.

Scale indicators6 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• D. Boral Capital: Independent investment bank focused on capital markets advisory and equity capital raises for small/mid-cap issuers. Directly comparable in services, transaction size range, and growth-company client profile.
• Alliance Global Partners (A.G.P.): Mid-market broker-dealer offering investment banking, institutional sales/trading, and equity research with strong Life Sciences and Technology verticals. Comparable to Weild & Co. in target deal size, vertical specialization, and capital markets services.
• Chardan Capital Markets: Full-service boutique investment bank with strong SPAC advisory, healthcare, and emerging-growth technology practices. Comparable in transaction services (especially SPAC advisory and small-cap IPOs) and vertical mix.
• Lake Street Capital Markets: Mid-market growth-focused investment bank serving public and private companies in consumer, healthcare, technology, and industrials. Closely comparable in target client size, services mix, and growth-company orientation.
• Aegis Capital Corp. Full-service broker-dealer providing investment banking, equity research, and institutional sales to micro-cap and small-cap issuers. Comparable mid-market focus, equity capital markets expertise, and vertical breadth.
• H.C. Wainwright & Co. Healthcare and life-sciences-focused investment bank providing capital markets, M&A, and equity research to small/mid-cap issuers. Directly comparable to Weild & Co.'s Life Sciences practice, which has completed 130+ M&A deals in the sector.
• Maxim Group: Full-service mid-market broker-dealer providing investment banking, research, and institutional sales to small/mid-cap companies across multiple verticals. Comparable in scale, services mix, and target issuer profile.
• EF Hutton: National full-service investment bank built on a decentralized network of independent registered representatives and investment banking professionals. Directly comparable to Weild & Co. in business model, mid-market focus, and FINRA broker-dealer structure.
• The Benchmark Company: Privately held investment bank providing equity research, institutional sales, and corporate finance to small/mid-cap issuers. Comparable in scale, structure, and focus on emerging growth companies.

Others

• Stonybrook Capital: Specialized financial services firm providing capital markets and advisory solutions across structured credit, public finance, and corporate finance. Listed as a strategic alliance partner and a relevant ecosystem peer rather than direct head-to-head competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/weild_co

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weild & Co.